SCHLEIFER LEONARD S 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Jun 10, 2024
Insider Transaction Report
Form 4
SCHLEIFER LEONARD S
DirectorCEO and President10% Owner
Transactions
- Sale
Common Stock
2024-06-06$1015.02/sh−787$798,821→ 64,198 total(indirect: By Trust)
Holdings
- 5,932(indirect: By 401(k))
Common Stock
- 466,877
Common Stock
- 157,552(indirect: 2023 GRAT)
Common Stock
Footnotes (2)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 5, 2024.
- [F2]Represents volume-weighted average price of sales of 787 shares of Company stock on June 6, 2024 at prices ranging from $1,015.00 to $1,015.25. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 6, 2024 at each separate price.